Sobi publishes Q4 2023 report: Strong revenue performance and growth into 2024 PR Newswire STOCKHOLM, Feb. 8, 2024 STOCKHOLM , Feb. 8, 2024 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the fourth quarter 2023 . Fourth Quarter 2023 Total revenue increased 14 per cent, 15 per cent at constant exchange rates, (CER), to SEK 6,844 M (5,991) Haematology revenue increased 21 per cent at CER to SEK 3,640 M (3,025), driven by sales of Vonjo ® of SEK 322 M ,...